ACADL antibody 17442-1-AP from Proteintech Group Inc | Biocompare.com

Supplier Images

ACADL antibody
ACADL antibody

Be the first to write a review!

Citations:

Supplier Page from
Proteintech Group Inc for
ACADL antibody

Description

The ACADL antibody from Proteintech is a rabbit polyclonal antibody to a recombinant protein of ACADL. This antibody recognizes recombinant protein antigen. The ACADL antibody has been validated for the following applications: WB, IHC, ELISA analysis

Product Specs
ItemACADL antibody
CompanyProteintech Group Inc
Price Pricing Info Supplier Page View Company Product Page
Catalog Number17442-1-AP
IsotypeIgG
Conjugate/TagUnconjugated
ReactivityHuman, Mouse, Rat
ClonalityPolyclonal
FormatPBS with 0.02% sodium azide and 50% glycerol pH 7.3
HostRabbit
Quantity20ul
ApplicationsWB, ELISA, IHC
PurityAntigen affinity purification
ImmunogenRecombinant Protein
NCBI Full Gene Nameacyl-CoA dehydrogenase long chain
NCBI Gene AliasesACAD4, LCAD
Research AreaCytoskeleton/Scaffold Proteins, Metabolism, Transport/Trafficking
TargetACADL
Antibody Typeprimary antibodies

Specifications/Features

20ul available

Add to Compare List

Proteintech Group Inc

Proteintech Group Inc

5500 Pearl Street, Suite 400

Rosemont,, Illinois 60018

United States

Phone: 1-888-478-4522

Email: proteintech@ptglab.com

Company Profile

Website: http://www.ptglab.com

(1) A HIF-1α inhibitor combined with palmitic acid and L-carnitine treatment can prevent the fat metabolic reprogramming under hypoxia and induce apoptosis in hepatocellular carcinoma cellsCancer MetabDecember 8, 2023Shohei Matsufuji, Yoshihiko Kitajima, Kazuki Higure, Naoya Kimura, Sachiko Maeda, Kohei Yamada, Kotaro Ito, Tomokazu Tanaka, Keita Kai, Hirokazu NoshiroCell Signaling Technology), MCAD (1:1000; cat. no. 55210–1-AP; Proteintech, Illinois, USA), LCAD (1:2000; cat. no. 17442–1-AP; Proteintech), ACSL1 (1:1000; cat. no. 13989–1-AP; Proteintech), AGPAT1 (1:1000; cat. no. 10601–1-AP;

(2) Chaperonin counteracts diet-induced non-alcoholic fatty liver disease by aiding sirtuin 3 in the control of fatty acid oxidationDiabetologiaMay 1, 2023Weng SW, Wu JC, Shen FC, Chang YH, Su YJ, Lian WS, Tai MH, Su CH, Chuang JH, Lin TK, et al.

(3) Lipidomics reveals the potential mechanism of honokiol against adenine-induced chronic kidney diseaseFrontiers in pharmacologyJanuary 1, 2022Liu X, Gao L, Huang X, Deng R, Wei X, Lu J, Li S.

(4) The serum acylcarnitines profile in epileptic children treated with valproic acid and the protective roles of peroxisome proliferator-activated receptor a activation in valproic acid-induced liver injuryFrontiers in pharmacologyJanuary 1, 2022Ma Y, Wang M, Guo S, Li T, Liu X, Zhao L.

(5) Enoyl-CoA hydratase-1 regulates mTOR signaling and apoptosis by sensing nutrientsNature communicationsSeptember 6, 2017Zhang YK, Qu YY, Lin Y, Wu XH, Chen HZ, Wang X, Zhou KQ, Wei Y, Guo F, Yao CF, et al.

Be the First to Write a Review!